Exos Asset Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Exos Asset Management’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,380	Closed	-$357K	–	334
2022 Q1	$357K	Buy	+35,380	New	+$355K	0.15%	142

Other funds holding APGN

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Exos Asset Management's APGN Position: Q2 2022 in Review

Exos Asset Management sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 35,380 shares — an estimated $357K sold.

Exos Asset Management first reported a position in APGN in Q1 2022 and held it in 1 quarter. The position peaked at $357K in Q1 2022. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

Exos Asset Management reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Exos Asset Management sold 35,380 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $357K.
Exos Asset Management first reported a position in Apexigen, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Exos Asset Management's Apexigen, Inc. Common Stock position peaked at $357K in Q1 2022.
27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.